PMC:7205724 / 79-297
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 173-180 | Species | denotes | patient | Tax:9606 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 53-68 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 10-34 | Chemical | denotes | immunosuppressive agents | http://purl.obolibrary.org/obo/CHEBI_35705 |
| T2 | 74-89 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T3 | 142-157 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T1 | 53-68 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulins | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 10-27 | http://purl.obolibrary.org/obo/IDO_0000610 | denotes | immunosuppressive |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 74-89 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T2 | 142-157 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 36-89 | Sentence | denotes | Anti-antibodies, immunoglobulins, and corticosteroids |
| T4 | 91-101 | Sentence | denotes | Highlights |
| T5 | 102-190 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 3 | 173-180 | Species | denotes | patient | Tax:9606 |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 1-9 | JJ | denotes | multiple |
| T14 | 10-27 | JJ | denotes | immunosuppressive |
| T15 | 28-34 | NNS | denotes | agents |
| T16 | 34-35 | -COLON- | denotes | : |
| T17 | 36-51 | NNS | denotes | Anti-antibodies |
| T18 | 51-52 | -COMMA- | denotes | , |
| T19 | 53-68 | NNS | denotes | immunoglobulins |
| T20 | 68-69 | -COMMA- | denotes | , |
| T21 | 70-73 | CC | denotes | and |
| T22 | 74-89 | NNS | denotes | corticosteroids |
| T23 | 91-101 | NNS | denotes | Highlights |
| T24 | 102-103 | IN | denotes | • |
| T25 | 105-109 | NNP | denotes | IVIG |
| T26 | 109-110 | -COMMA- | denotes | , |
| T27 | 111-119 | VBN | denotes | combined |
| T28 | 120-124 | IN | denotes | with |
| T29 | 125-138 | NN | denotes | moderate-dose |
| T30 | 139-141 | IN | denotes | of |
| T31 | 142-157 | NNS | denotes | corticosteroids |
| T32 | 157-158 | -COMMA- | denotes | , |
| T33 | 159-164 | MD | denotes | might |
| T34 | 165-172 | VB | denotes | improve |
| T35 | 173-180 | NN | denotes | patient |
| T36 | 181-189 | NNS | denotes | outcomes |
| T37 | 191-192 | PDT | denotes | • |
| T38 | 194-197 | DT | denotes | The |
| T39 | 198-201 | NN | denotes | use |
| T40 | 202-204 | IN | denotes | of |
| R12 | T15 | T13 | arg1Of | agents,multiple |
| R13 | T15 | T14 | arg1Of | agents,immunosuppressive |
| R15 | T17 | T18 | arg1Of | Anti-antibodies,"," |
| R16 | T19 | T18 | arg2Of | immunoglobulins,"," |
| R17 | T21 | T20 | arg1Of | and,"," |
| R18 | T18 | T21 | arg1Of | ",",and |
| R19 | T22 | T21 | arg2Of | corticosteroids,and |
| R20 | T25 | T24 | arg1Of | IVIG,• |
| R21 | T25 | T26 | arg1Of | IVIG,"," |
| R22 | T25 | T27 | arg2Of | IVIG,combined |
| R23 | T27 | T28 | arg1Of | combined,with |
| R24 | T29 | T28 | arg2Of | moderate-dose,with |
| R25 | T29 | T30 | arg1Of | moderate-dose,of |
| R26 | T31 | T30 | arg2Of | corticosteroids,of |
| R27 | T34 | T32 | arg1Of | improve,"," |
| R28 | T25 | T33 | arg1Of | IVIG,might |
| R29 | T34 | T33 | arg2Of | improve,might |
| R30 | T25 | T34 | arg1Of | IVIG,improve |
| R31 | T36 | T34 | arg2Of | outcomes,improve |
| R32 | T36 | T35 | arg1Of | outcomes,patient |
| R33 | T39 | T37 | arg1Of | use,• |
| R34 | T39 | T38 | arg1Of | use,The |
| R35 | T39 | T40 | arg1Of | use,of |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 53-68 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 36-89 | Sentence | denotes | Anti-antibodies, immunoglobulins, and corticosteroids |
| T4 | 91-101 | Sentence | denotes | Highlights |
| T5 | 102-190 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |